Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Proto Labs (NYSE:PRLB - Get Rating) updated its third quarter 2022 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $0.36-$0.44 for the period. The company issued revenue guidance of $121.00 million-$129.00 million, compared to the consensus revenue estimate of $133.27 million. Proto Labs Stock Performance

Shares of PRLB opened at $38.20 on Monday. Proto Labs has a 52-week low of $37.35 and a 52-week high of $79.27. The business's 50 day moving average price is $46.17 and its two-hundred day moving average price is $48.10. The firm has a market cap of $1.05 billion, a PE ratio of 43.41 and a beta of 1.33.

Proto Labs (NYSE:PRLB - Get Rating) last issued its quarterly earnings results on Friday, August 5th. The industrial products company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.07. Proto Labs had a return on equity of 2.95% and a net margin of 4.88%. The firm had revenue of $126.90 million for the quarter, compared to analyst estimates of $127.28 million. During the same period in the previous year, the firm earned $0.47 earnings per share. The company's revenue was up 3.2% compared to the same quarter last year. Research analysts predict that Proto Labs will post 0.79 EPS for the current fiscal year. Wall Street Analysts Forecast Growth

PRLB has been the subject of a number of analyst reports. StockNews.com upgraded shares of Proto Labs from a hold rating to a buy rating in a report on Monday, August 8th. Craig Hallum dropped their price target on shares of Proto Labs to $42.00 in a research report on Monday, August 15th.Hedge Funds Weigh In On Proto Labs

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. grew its stake in Proto Labs by 5.1% in the 1st quarter. Vanguard Group Inc. now owns 2,848,640 shares of the industrial products company's stock worth $150,693,000 after buying an additional 137,885 shares in the last quarter. State Street Corp lifted its holdings in shares of Proto Labs by 8.2% in the 2nd quarter. State Street Corp now owns 1,120,464 shares of the industrial products company's stock worth $53,603,000 after acquiring an additional 85,135 shares during the last quarter. Federated Hermes Inc. lifted its holdings in shares of Proto Labs by 63.4% in the 1st quarter. Federated Hermes Inc. now owns 461,748 shares of the industrial products company's stock worth $24,426,000 after acquiring an additional 179,112 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Proto Labs by 34.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 426,194 shares of the industrial products company's stock worth $22,547,000 after acquiring an additional 108,638 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Proto Labs by 8.8% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 260,507 shares of the industrial products company's stock worth $13,781,000 after acquiring an additional 21,157 shares during the last quarter. Hedge funds and other institutional investors own 88.86% of the company's stock. About Proto Labs (Get Rating)

Proto Labs, Inc, together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom prototypes and on-demand production parts in the worldwide. The company offers injection molding; computer numerical control machining; three-dimensional (3D) printing, which include stereolithography, selective laser sintering, direct metal laser sintering, multi jet fusion, polyjet, and carbon DLS processes; and sheet metal fabrication products, including quick-turn and e-commerce-enabled custom sheet metal parts.Further ReadingGet a free copy of the StockNews.com research report on Proto Labs (PRLB)Could Snap Stock Rebound As Management Restructures?MarketBeat: Week in Review 8/29 – 9/2Hormel Looks Cheap At These Levels Lululemon Set To Soar Into SeptemberCould Nike Stock be Oversold, but Still Overvalued?

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Proto Labs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Proto Labs wasn't on the list.

While Proto Labs currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Michael Wang of Prometheus Alternative Investments discusses how individuals should approach their portfolios as the summer rally seems to have fizzled.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.